CUV 1.42% $13.90 clinuvel pharmaceuticals limited

2024 Catalyst Countdown, page-7

  1. 489 Posts.
    lightbulb Created with Sketch. 276
    And several six to ten patient proof of concept trials that announce promising results for the first three then disappear back into the Clinuvelian strategic darkness
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.